About Minerva Surgical
Minerva Surgical is a company based in Redwood City (United States) founded in 2008. It operates as a Direct-to-Consumer (D2C), and Professional Services. Minerva Surgical has raised $135.1 million across 16 funding rounds from investors including Accelmed and NEA. The company has 155 employees as of December 31, 2022. Minerva Surgical offers products and services including Minerva EAS, Symphion, Genesys HTA, Resectr, and HERizon. Minerva Surgical operates in a competitive market with competitors including Gynesonics, Channel Medsystems, LUMINELLE, Interlace Medical and Endosee, among others.
- Headquarter Redwood City, United States
- Employees 155 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Minerva Surgical, Inc.
-
Annual Revenue
$50.29 M-3.47as on Dec 31, 2022
-
Net Profit
$-34.11 M-58.93as on Dec 31, 2022
-
EBITDA
$-28.56 M-57.82as on Dec 31, 2022
-
Total Equity Funding
$135.1 M (USD)
in 16 rounds
-
Latest Funding Round
-
Investors
Accelmed
& 1 more
-
Employee Count
155
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Minerva Surgical
Minerva Surgical is a publicly listed company on the OTC with ticker symbol UTRS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Minerva Surgical
Minerva Surgical offers a comprehensive portfolio of products and services, including Minerva EAS, Symphion, Genesys HTA, Resectr, and HERizon. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Endometrial ablation system using multiple tissue ablation methods.
Operative hysteroscopy system for fibroid and polyp removal.
Endometrial ablation device with continuous direct visualization feature.
Tissue resection device designed for ease and control.
Disposable hysteroscopy system for in-office diagnostic evaluation.
Unlock access to complete
Unlock access to complete
Funding Insights of Minerva Surgical
Minerva Surgical has successfully raised a total of $135.1M across 16 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 16
- Last Round Last Round
-
First Round
First Round
(07 Jan 2009)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Post-IPO - Minerva Surgical | Valuation |
investors |
|
| May, 2020 | Amount | Debt – Conventional - Minerva Surgical | Valuation |
investors |
|
| Nov, 2019 | Amount | Debt – Conventional - Minerva Surgical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Minerva Surgical
Minerva Surgical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Accelmed and NEA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Minerva Surgical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Minerva Surgical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Minerva Surgical Comparisons
Competitors of Minerva Surgical
Minerva Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gynesonics, Channel Medsystems, LUMINELLE, Interlace Medical and Endosee, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A minimally invasive ablation system for uterine fibroids is developed.
|
|
| domain | founded_year | HQ Location |
Cryothermic technology for endometrial ablation to control heavy bleeding
|
|
| domain | founded_year | HQ Location |
Hysteroscopy system is developed for minimally invasive endometrial procedures.
|
|
| domain | founded_year | HQ Location |
Gynecological devices for office-based procedures are designed and developed.
|
|
| domain | founded_year | HQ Location |
Disposable office-based hysteroscopy systems are developed for gynecological procedures.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Minerva Surgical
Frequently Asked Questions about Minerva Surgical
When was Minerva Surgical founded?
Minerva Surgical was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is Minerva Surgical located?
Minerva Surgical is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Who is the current CEO of Minerva Surgical?
David Clapper is the current CEO of Minerva Surgical.
Is Minerva Surgical a funded company?
Minerva Surgical is a funded company, having raised a total of $135.1M across 16 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $10M, raised on Jan 07, 2009.
How many employees does Minerva Surgical have?
As of Dec 31, 2022, the latest employee count at Minerva Surgical is 155.
What is the annual revenue of Minerva Surgical?
Annual revenue of Minerva Surgical is $50.29M as on Dec 31, 2022.
What does Minerva Surgical do?
Minerva Surgical, Inc. is dedicated to advancing womens uterine health through innovative medical devices. The company specializes in minimally invasive intrauterine treatments for Abnormal Uterine Bleeding (AUB), offering a comprehensive suite of products designed for safety, efficiency, and effectiveness. Solutions are provided for both normal and irregular-shaped uteri, addressing root causes with technologies like endometrial ablation and hysteroscopy systems. Support, training, and education are extended to healthcare professionals across various settings, including hospitals and private practices. The focus remains on gynecologic surgery advancements within the healthcare sector.
Who are the top competitors of Minerva Surgical?
Minerva Surgical's top competitors include Gynesonics, Channel Medsystems and LUMINELLE.
What products or services does Minerva Surgical offer?
Minerva Surgical offers Minerva EAS, Symphion, Genesys HTA, Resectr, and HERizon.
Is Minerva Surgical publicly traded?
Yes, Minerva Surgical is publicly traded on OTC under the ticker symbol UTRS.
Who are Minerva Surgical's investors?
Minerva Surgical has 2 investors. Key investors include Accelmed, and NEA.
What is Minerva Surgical's ticker symbol?
The ticker symbol of Minerva Surgical is UTRS on OTC.